Stem cell therapy has surprising potential for treatment of several presently incurable diseases. Embryo and cord blood stem sells have different properties than adult cells found in organs. Kwang Yul Cha is a world renown South Korean medical doctor in the field of reproduction and fertility. He is a foremost expert in this promising new field of research and treatment.
Most incurable disease is of a degenerative type. Accelerated aging or injury cause specific cell types to be lost or destroyed. This leads to functional degeneration. Regeneration of the lost tissue has been very difficult, or impossible up to now.
Gene, or stem cell therapy has already been in use for some time in regeneration of bone marrow after radiation treatment for leukemia. The cells are extracted from the bone marrow pretreatment, and then inserted again after treatment for regeneration. Currently there is also application for urinary incontinence.
The future looks promising for applications of this technology. Cancer, traumatic brain injury, degenerative brain disease, stroke spinal injury, Alzheimer's, neuronal disease, ALS, Parkinson's, MS, myocardial infarction, muscular dystrophy, diabetes, and Crohn's disease are all issues that may someday soon be addressed with this science. Others that are not life threatening include deafness, blindness, arthritis, baldness, and missing teeth.
Specialized adult stem cells are located in the various tissues of the body where they act to repair and regenerate those tissues. Embryonic and cord blood stem cells are progenitors. They have the additional capacity to reproduce themselves, and to differentiate into the various specialized types, such as cartilage, bone, liver, and blood, as well.
Cha Medical Stem Cell Institute and Cha Biotech are working in several areas of application in this new technological field. They are cryopreserving or freezing embryo cord blood and embryos for future use by the donor to treat disease or to make reproduction possible after cancer treatment or advanced age. They have achieved a 90% survival rate of frozen and thawed eggs, and a 65% pregnancy rate. They produced the first test tube baby in 1999.
Currently they are producing cell lines and conducting research in several areas including cytogenesis, gene therapy for tumor suppression, genetic manipulation, and developing artificial organs. These sciences have been advanced considerably at the Korean and American facilities.
Kwang Yul Cha graduated from the school of medicine in Yonsei University in Seoul. He completed his postdoctoral fellowship with University of Southern California and has been visiting professor at Columbia. Over 100 of his reproductive and stem cell science articles have been published in peer reviewed journals.
Kwang Yul Cha
Most incurable disease is of a degenerative type. Accelerated aging or injury cause specific cell types to be lost or destroyed. This leads to functional degeneration. Regeneration of the lost tissue has been very difficult, or impossible up to now.
Gene, or stem cell therapy has already been in use for some time in regeneration of bone marrow after radiation treatment for leukemia. The cells are extracted from the bone marrow pretreatment, and then inserted again after treatment for regeneration. Currently there is also application for urinary incontinence.
The future looks promising for applications of this technology. Cancer, traumatic brain injury, degenerative brain disease, stroke spinal injury, Alzheimer's, neuronal disease, ALS, Parkinson's, MS, myocardial infarction, muscular dystrophy, diabetes, and Crohn's disease are all issues that may someday soon be addressed with this science. Others that are not life threatening include deafness, blindness, arthritis, baldness, and missing teeth.
Specialized adult stem cells are located in the various tissues of the body where they act to repair and regenerate those tissues. Embryonic and cord blood stem cells are progenitors. They have the additional capacity to reproduce themselves, and to differentiate into the various specialized types, such as cartilage, bone, liver, and blood, as well.
Cha Medical Stem Cell Institute and Cha Biotech are working in several areas of application in this new technological field. They are cryopreserving or freezing embryo cord blood and embryos for future use by the donor to treat disease or to make reproduction possible after cancer treatment or advanced age. They have achieved a 90% survival rate of frozen and thawed eggs, and a 65% pregnancy rate. They produced the first test tube baby in 1999.
Currently they are producing cell lines and conducting research in several areas including cytogenesis, gene therapy for tumor suppression, genetic manipulation, and developing artificial organs. These sciences have been advanced considerably at the Korean and American facilities.
Kwang Yul Cha graduated from the school of medicine in Yonsei University in Seoul. He completed his postdoctoral fellowship with University of Southern California and has been visiting professor at Columbia. Over 100 of his reproductive and stem cell science articles have been published in peer reviewed journals.
Kwang Yul Cha
